There are currently 121 clinical trials in Eugene, Oregon looking for participants to engage in research studies. Trials are conducted at various facilities, including Oregon Research Institute, Willamette Valley Cancer Institute and Research Center, University of Oregon and GSK Investigational Site. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Evaluation of Lower Extremity Athletic Injuries and Response to Treatment Using SWE and MFI
Recruiting
Primary Objective: To explore changes in shear wave elastography (SWE) and microvascular flow imaging (MFI) measurements from time of injury through the recovery phase of lower extremity musculoskeletal injuries to determine if a correlation exists with functional impairment. Secondary Objective: To develop a deep learning AI system for automated region of interest (ROI) determination for measurement of average SWE and MFI. Methodology: Eligible subjects with lower extremity injuries will u... Read More
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
12/13/2023
Locations: University of Oregon, Eugene, Oregon
Conditions: Lower Extremity Musculoskeletal Injury
Comprehensive Adaptive Multisite Prevention of University Student Suicide
Recruiting
Suicide is the 2nd leading cause of death among college students and suicidal ideation and suicide-related behaviors are a frequent presenting problem at college counseling centers (CCCs), which are overburdened. Studies show that some students respond rapidly to treatment, whereas others require considerably more resources. Evidence-based adaptive treatment strategies (ATSs) are needed to address this heterogeneity in responsivity and complexity. ATSs individualize treatment via decision rules... Read More
Gender:
All
Ages:
Between 18 years and 25 years
Trial Updated:
12/07/2023
Locations: University of Oregon, Eugene, Oregon
Conditions: Suicide
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
Recruiting
This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer and other Gynecologic Malignancies.
Gender:
Female
Ages:
18 years and above
Trial Updated:
12/05/2023
Locations: Willamette Valley Cancer Institute and Research Center, Eugene, Oregon
Conditions: Endometrioid Endometrial Cancer
Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders
Recruiting
Most people with an eating disorder (ED) do not receive good treatment. The investigators have developed a new brief group treatment that is supposed to work by reducing how much women with an ED value the impossible thinness standard promoted by the media and how much they value/crave binge foods. The investigators want to test whether the treatment actually changes those two mechanisms using brain scan data, which is more objective than completing questionnaires and even interviews. In the fi... Read More
Gender:
Female
Ages:
Between 18 years and 34 years
Trial Updated:
11/17/2023
Locations: Oregon Research Institute, Eugene, Oregon
Conditions: Eating Disorder
PRISM Intervention Study
Recruiting
This research study, Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM), is designed to maximize language outcomes for limited-language preschoolers, thereby lowering the risk of being classified as "minimally verbal" at age 6, by empirically developing a two-stage, 20-week adaptive intervention approach in a real world community settings. If found efficacious, the adaptive intervention design will capitalize on the heterogeneity and evolving status... Read More
Gender:
All
Ages:
Between 36 months and 59 months
Trial Updated:
11/03/2023
Locations: University of Oregon, Eugene, Oregon
Conditions: Autism Spectrum Disorder
Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors
Recruiting
The primary purpose of this study is to assess the safety and tolerability of niraparib or olaparib in combination with RP-3500 (camonsertib), in patients with eligible advanced solid tumors, determine the maximum tolerated dose (MTD) of RP-3500 (camonsertib) in combination with niraparib or olaparib, examine pharmacokinetics (PK) and assess anti-tumor activity.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/02/2023
Locations: Participating Site #1029, Eugene, Oregon
Conditions: Advanced Solid Tumor, Adult
Teen Weight Control
Recruiting
The prevalence of obesity in adolescents is remarkably high, with 38.7% of youth 12-15 years of age and 41.5% of 16-19 year olds meeting criteria for overweight or obesity. Behavioral weight control interventions for adolescents have had limited impact on this field and there is considerably more that needs to be done. Notably, adolescents who have difficulty managing their feelings have been found to consume higher caloric foods and report greater amounts of sedentary time. Poor emotion managem... Read More
Gender:
All
Ages:
Between 13 years and 17 years
Trial Updated:
10/18/2023
Locations: University of Oregon, Eugene, Oregon
Conditions: Adolescent Obesity, Weight Loss
Study of Effect of Azeliragon in Patients Refractory to First-Line Metastatic Pancreatic Cancer
Recruiting
This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to first-line or second-line treatment of metastatic pancreatic cancer.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/09/2023
Locations: Williamette Valley Cancer Institute and Research Center, Eugene, Oregon
Conditions: Metastatic Pancreatic Cancer
C-Protein in Fatigue and Aging
Recruiting
This study is investigating changes to the proteins in skeletal muscle that contribute to reduced muscle size and muscle function that occurs with aging.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/06/2023
Locations: University of Oregon, Eugene, Oregon
Conditions: Aging, Muscle Atrophy or Weakness, Sarcopenia in Elderly, Sarcopenia
Histamine as a Molecular Transducer of Adaptation to Exercise
Recruiting
This study is investigating the role of histamine in generating adaptation to exercise
Gender:
All
Ages:
Between 18 years and 40 years
Trial Updated:
10/06/2023
Locations: University of Oregon, Eugene, Oregon
Conditions: Postexercise Hypotension
Supported Employment COVID-19 Rapid Testing for PWID
Recruiting
This community-engaged project aims to improve the accessibility of rapid tests through a supported employment program for people who inject drugs (PWID). The program is called Peer Connect2Test (PeerC2T). PWID will be recruited by a community partner who provides syringe exchange services. PWID will the trained by the community partner to become peer health workers (PHW) to distribute SARS-CoV-2 rapid tests to other PWID. Investigators expect that PeerC2T will improve knowledge, self-efficacy,... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/06/2023
Locations: University of Oregon, Eugene, Oregon
Conditions: Health Behavior
Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR
Recruiting
Young parents aged 16 to 30, involved in the DHS system for child welfare or self-sufficiency needs are at risk for opioid use disorder and/or methamphetamine use disorder (OUD; MUD). Those identified as engaging in opioid or methamphetamine misuse are at high risk for escalation. Children of parents with OUD and MUD are at-risk for entering into foster care. Oregon is one state particularly affected by this challenge. The proposed UG3/UH3 offers one potential solution by adapting and evaluating... Read More
Gender:
All
Ages:
Between 16 years and 30 years
Trial Updated:
09/14/2023
Locations: OSLC, Eugene, Oregon
Conditions: Opioid-Related Disorders, Stimulant-Related Disorder, Child Neglect, Mental Health Impairment